Astex Pharmaceuticals, Inc. (NASDAQ:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced the Agenda for its Annual Analyst and Investor Day webcast, to take place from 10 am to 12 pm ET on Tuesday, March 27th in New York. Investors and interested parties may access the webcast in the Investor Events section of the Company's website, www.astx.com. A webcast replay will be available for 90 days following the live event.
|10:00 (5 min.)||Welcome and Introductions||Timothy L. EnnsSVP, Corporate Communications and Marketing|
|10:05 (15 min.)||Corporate Overview||James S. J. Manuso, Ph.D.Chairman and Chief Executive Officer|
|10:20 (15 min.)||Financial Overview||Michael Molkentin, C.P.A.Chief Financial Officer and Corporate Secretary|
|10:35 (15 min.) 10:50 (20 min.)||Clinical UpdateSGI-110 & HMAs||Mohammad Azab, M.D.Chief Medical Officer Jean-Pierre Issa, MDFels Institute of Cancer ResearchTemple University, Philadelphia, PA|
|11:10 (20 min.)||AT 13387 & HSP90 inhibitors||Andrew Wagner, MD, PhDDana Farber Cancer Institute, Boston, MA|
|11:30 (15 min.) 11:45 (15 min.)||Research & DiscoveryPartnering & Corporate Development||Harren Jhoti, Ph.D.President and Director Martin BucklandChief Business Officer|
|12:00 (5 min.)||Closing Remarks||James S. J. Manuso, Ph.D.Chairman and Chief Executive Officer|
About Astex PharmaceuticalsAstex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed Dacogen® (decitabine) for Injection and receives significant royalties on global sales. For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.